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Enteroviruses are environmental triggers in the pathogenesis of type 1 diabetes mellitus (DM). A sequence
of six identical amino acids (PEVKEK) is shared by the 2C protein of Coxsackie virus B and the glutamic
acid decarboxylase (GAD) molecules. Between 1995 and 2002, we investigated 22 Coxsackie virus B5 (CVB5)
isolates from southern Taiwan. Four of these isolates were obtained from four new-onset type 1 DM patients
with diabetic ketoacidosis. We compared a 300 nucleotide sequence in the 2C protein gene (p2C) in
24 CVB5 isolates (4 diabetogenic, 18 non-diabetogenic and 2 prototype). We found 0.3–10% nucleotide
differences. In the four isolates from type 1 DM patients, there was only 2.4–3.4% nucleotide difference,
and there was only 1.7–7.1% nucleotide difference between type 1 DM isolates and non-diabetogenic
isolates. Comparison of the nucleotide sequence between prototype virus and 22 CVB5 isolates revealed
18.4–24.1% difference. Twenty-one CVB5 isolates from type 1 DM and non-type 1 DM patients contained
the PEVKEK sequence, as shown by the p2C nucleotide sequence. Our data showed that the viral p2C
sequence with homology with GAD is highly conserved in CVB5 isolates. There was no difference between
diabetogenic and non-diabetogenic CVB5 isolates. All four type 1 DM patients had at least one of the
genetic susceptibility alleles HLA-DR, DQA1, DQB1. Other genetic and autoimmune factors such as HLA
genetic susceptibility and GAD may also play important roles in the pathogenesis in type 1 DM.
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Type 1 diabetes mellitus (DM) results from the progressive
destruction of pancreatic beta cells. Environmental factors
are believed to play an important role in the development
of type 1 DM by influencing the penetrance of diabetes
susceptibility genes. Viruses, especially enteroviruses, have
long been considered to play a part in this disease [1–3],
based on several serologic and epidemiologic studies [4,5].
Diagnostic tests for enteroviruses include viral isolation,
immunologic methods and the polymerase chain reaction
(PCR). Traditionally, viral isolation in cell culture is the gold
standard of enterovirus diagnosis. However, diagnosis by
cell culture is relatively slow, requires significant technical
expertise and may not succeed for certain enterovirus
serotypes and/or certain clinical situations. Immunologic
methods based on antigen or antibody detection have been
limited by the absence of a single common antigen among
the enteroviruses [6].
Very few reports have described viral isolation associ-
ated with the development of type 1 DM. In 1979, Yoon et
al first reported the isolation of a virus from the pancreas
of a child with diabetic ketoacidosis [7]. In 1982, Champ-
saur et al reported isolation of a Coxsackie virus from a child
dying of type 1 DM, and demonstrated that these isolated
viruses could induce diabetes in mice [8]. However, there
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are several reports that viral isolates do not induce diabetes
in mice [9–11].
During the period 1995–1998, we investigated the as-
sociation between Coxsackie virus infection and type 1
DM through viral isolation and serologic methods. We
found four Coxsackie virus B5 (CVB5) isolates in throat
swabs or stool specimens from 38 consecutive new-onset
type 1 DM patients admitted with diabetic ketoacidosis or
ketosis. There was an epidemic of CVB5 infection during
that period in southern Taiwan. All four of the children with
CVB5 isolates suffered from type 1 DM, while the other
children suffered from aseptic meningitis, pneumonia or
other diseases. We were interested in whether there was
a significant difference in nucleotide sequence between
diabetogenic and non-diabetogenic CVB5 isolates.
The 2C protein is a non-structural protein with large-
ly unknown function. It is apparently required in the ini-
tiation and elongation phases in RNA synthesis [12]. A se-
quence of six identical amino acids is shared by the 2C
protein of Coxsackie virus B4 and the 65 kDa glutamic
acid decarboxylase (GAD65) molecule, which is a major
autoantigen in type 1 DM (so-called molecular mimicry)
[13–19]. Studies analyzing the possible role of molecular
mimicry in type 1 DM have been largely focused on this
sequence [20].
The main purposes of this study were to find the dif-
ferences in the nucleotide sequence of the gene encoding
the 2C protein (p2C), and to compare the frequency of the
amino acid PEVKEK sequence, between diabetogenic and
non-diabetogenic CVB5 isolates.
MATERIALS AND METHODS
Between 1995 and 2002, we randomly investigated 22
CVB5 isolates in southern Taiwan. Twenty CVB5 isolates
were obtained from the Division of Virology, Department
of Laboratory Medicine, Kaohsiung Medical University
(KMU) Hospital. The other two CVB5 isolates were kind-
ly provided by Kaohsiung Chang-Kang Hospital. Four of
the 22 CVB5 isolates came from four children with type
1 DM. These four CVB5 strains were isolated from 38
consecutive throat swabs or rectal/stool specimens col-
lected, within 4 days after admission, from new-onset type
1 DM patients admitted with ketoacidosis between 1995
and 1998. All four type 1 DM patients suffered from
symptoms such as polyuria, polydipsia, polyphagia, fever,
vomiting or abdominal pain several days prior to their
admission. Three of these patients had blood pH values
less than 7.3 at admission.
Human leukocyte antigen (HLA)-DR and HLA-DQA1,
DQB1 studies were performed using the sequence-specific
primer methods developed by Olerup et al [21,22]. All
CVB5 isolates were identified using a neutralization test
with type-specific antiserum against the protype strain
of CVB5. HeLa cells were grown in culture with Hanks
minimum essential medium supplemented with 10% calf
serum, and used to isolate viruses from throat swabs and
stool specimens. After complete cytopathic effect (CPE)
was reached, the cultures were frozen and thawed three
times.
RNA was extracted using a single extraction procedure
[23]. Reverse transcription-PCR was performed as pre-
viously described [24]. Briefly, cDNA was synthesized
in a 20 µL reaction mixture containing 75 mmol/L KCl,
50 mmol/L Tris-HCl pH 8.3, 3 mmol/L MgCl2, 10 mmol/L
dithiothreitol, 0.2 mmol/L of each dNTP (Promega Corp,
Madison, WI, USA), 50 pmol of the denatured antisense
primer (5’-TCTTCACCGTGGCGGTGGCTCAAACA-3’), 5
units of avian myeloblastosis virus reverse transcriptase
(Promega Corp) and extracted RNA. After incubation at
37°C for 60 minutes, 80 µL of the PCR mixture was added.
The PCR mixture contained 50 mmol/L KCl, 10 mmol/L
Tris-HCl pH 8.9, 3.6 mmol/L MgCl2, 0.2 mmol/L of each
dNTP, 100 µg/nL bovine serum albumin, 80 pmol of sense
primer (5’-GCATTTGGACTTGACTGTATG-3’), 40 pmol of
antisense primer (5’-TCTTCACCGTGGCGGTGGCTC-
AAACA-3’), and 0.2 units of Taq DNA polymerase (Promega
Corp).
RNA–cDNA hybrids were denatured at 94°C for 5
minutes. Amplification was performed in 40 cycles con-
sisting of denaturation at 94°C for 45 seconds, annealing
at 58°C for 30 seconds, and elongation at 72°C for 50 sec-
onds. The reactions were analyzed by electrophoresis at
1.5 v in agarose gels, and the product was purified from
low-melting point agarose with a DNA purification system
(Promega Corp), according to the manufacturer’s instruc-
tions. DNA sequence analysis was performed using the
Ampli Cycle sequence kit, according to the manufacturer’s
instructions, in an automated sequencer (ABI PRISM 310;
Perkin Elmer, Foster City, CA, USA).
A 300 nucleotide sequence of p2C in 22 CVB5 isolates
was compared with that of two published CVB5 prototypes
(gi-59045 and gi-6650682) using nucleotide comparison
software (NCBI-Blast and DNASTAR-John Hein methods).
Accession numbers of the nucleotide sequences
The p2C nucleotide sequences of the 22 CVB5 isolates
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reported in this paper appear in the GenBank nucleotide
sequence database with the following accession numbers:
522/95, AY738592; 855/95, AY744161; 892/95, AY744162;
811/97, AY744163; 677/95, AY744164; 790/95, AY744165;
851/95, AY744166; 852/95, AY744167; 886/95, AY744168;
889/95, AY744169; 894/95, AY744170; 059/96, AY744171;
064/96, AY744172; 068/96, AY744173; 072/96, AY744174;
080/96, AY744175; 081/96, AY744176; 1214/9, AY744177;
212/96, AY744178; 524/98, AY744179; 0090/98, AY744180;
3203/98, AY744181.
RESULTS
Most specimens of the CVB5 isolates were obtained from
throat swab and stool specimens (Table 1). Only one CVB5
isolate came from cerebrospinal fluid in an aseptic men-
ingitis patient. All CVB5 isolates reached CPE in HeLa
cells. There was no significant difference in mean time to
CPE between diabetogenic and non-diabetogenic CVB5
isolates. Table 2 shows the demographic characteristics
and laboratory results for the four type 1 DM patients.
Table 1. Clinical characteristics and specimen source of 22 Coxsackie virus B5 isolates
Isolate Specimen Diagnosis CPE, days Month isolated
KMU95-522 Rectal swab Type 1 DM 2 1995/10
KMU95-677 Throat swab URI, CHD 3 1995/11
KMU95-790 Stool AGE 6 1995/12
KMU95-851 Throat swab Pneumonia 6 1996/01
KMU95-852 Stool Viral meningitis 4 1996/01
KMU95-855 Throat swab Type 1 DM 4 1996/01
KMU95-886 Throat swab Viral meningitis 4 1996/01
KMU95-889 Throat swab Pneumonia 5 1996/01
KMU95-892 Throat swab Type 1 DM 2 1996/01
KMU95-894 Throat swab Pneumonia 4 1996/01
KMU96-059 Throat swab Pneumonia 5 1996/01
KMU96-064 Throat swab Sepsis 5 1996/01
KMU96-068 Throat swab Viral meningitis 3 1996/01
KMU96-072 Stool Fever 5 1996/01
KMU96-080 Throat swab Pneumonia 4 1996/02
KMU96-081 Stool AGE 4 1996/02
KMU96-1213 Throat swab Acute bronchitis 2 1996/09
KMU96-212 Throat swab Status asthmaticus 2 1996/03
KMU97-811 Throat swab Type 1 DM 4 1997/12
KMU98-524 CSF Viral meningitis 4 1998/07
KCK98-090 Throat swab Viral encephalitis NA 1998
KCK02-3203 Rectal swab AGE, seizure NA 2002
CPE = complete cytopathic effect; DM = diabetes mellitus; URI = upper respiratory tract infection; CHD = congenital heart disease; AGE =
acute gastroenteritis; CSF = cerebrospinal fluid; NA = not available.
Table 2. Demographic characteristics and laboratory results of four type 1 diabetes mellitus patients
Case Gender/Age, yr Duration, yr GAD HLA Serology
DR DQA1 DQB1 Acute Conv
1 F /5 4 Neg 2, 4 0103, 0302 0401, 0602 16 32
2 F /14 5 50.9 3, 4 0301, 0501 0201, 0401 4 NA
3 M /1 2 Neg 4, 9 0301, 0301 0201, 0301 32 NA
4 M /6 3 7.1 3, 11 0501, 0501 0201, 0301 8 NA
GAD = glutamic acid decarboxylase; HLA = human leukocyte antigen; DR = D-related; Conv = convalescence; F = female; Neg = negative;
NA = not available; M = male.
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Table 3 shows the seasonal distribution of enterovirus
and CVB5 isolates in the Department of Virology at KMU
Hospital. Thirteen of 29 (44.8%) enterovirus isolates in
December 1995 and 10 of 11 (90.9%) enterovirus isolates
in January 1996 were CVB5. Thus, there was a CVB5 epi-
demic during winter 1995/96.
In Table 4, the amino acid sequence of CVB5 isolates are
compared. Except for CVB5 isolate 96-1214, the p2C 300
nucleotide sequence in both diabetogenic and non-
diabetogenic CVB5 isolates contained the section coding
Table 3. Seasonal distribution of enterovirus (EV) and Coxsackie virus B5 (CVB5) isolates at Kaohsiung Medical University
Hospital during 1995–1998
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
1995
EV 0 0 1 0 3 0 2 3 10 17 13 29
CVB5 0 0 0 0 0 0 1 3 6 0 2 13
1996
EV 11 2 0 0 30 21 13 2 6 3 1 12
CVB5 10 1 0 0 0 0 0 0 3 0 0 0
1997
EV 0 1 2 3 24 9 3 4 3 11 6 2
CVB5 0 0 0 0 0 0 0 0 1 3 1 0
1998
EV 4 5 52 4 25 82 25 14 11 22 4 4
CVB5 0 0 0 1 1 0 2 0 1 0 0 1
Table 4. Amino acid sequence comparison of Coxsackie virus B5 isolates
Identical amino acid residues are indicated by “.”; non-homologous amino acid residues are indicated by their single-letter code.
Coxsackie virus B5 nucleotide sequence comparison
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for PEVKEK, which is also conserved in the nucleotide se-
quence of GAD, the main autoantigen of type 1 DM.
Comparisons of this 300 nucleotide sequence in 22
diabetogenic or non-diabetogenic CVB5 isolates and two
prototype CVB5 isolates revealed 0.3–10% nucleotide dif-
ference. Among the four CVB5 isolates from the type 1 DM
patients, there was only 2.4–3.4% nucleotide difference,
and there was only 1.7–7.1% nucleotide difference between
these type 1 DM isolates and the non-diabetogenic CVB5
isolates. The CVB5 isolate KMU98-524 had the greatest
nucleotide difference from other CVB5 isolates (5.2–10%).
Comparison of nucleotide sequences between prototype
isolates and these 22 CVB5 isolates revealed 18.4–24.1%
difference (Figure).
DISCUSSION
Diseases with seasonal incidence are often caused by viral
infections. There have been many anecdotal reports of a
viral infection preceding or coinciding with the onset of
type 1 DM [25], as well as case reports of virus isolation
from the pancreas of patients who have died of acute
diabetes, and reports of induction of diabetes in suscepti-
ble animals by infection with isolated viruses [7]. In this
study, most CVB5 strains were isolated in the winter.
Kopecka et al found that CVB5 isolates from the same
outbreak were closely related, not exceeding 7.2% nucleo-
tide difference, and that the differences were greater be-
tween isolates from different outbreaks, varying between
Figure. Dendrogram illustrating
sequence relationships among the
22 Coxsackie virus B5 isolates
and two published prototypes.
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8.4% and 16% [26]. Their studies also revealed that CVB5
from an outbreak in 1967 was more similar to viruses from
an outbreak in 1983 than to those isolated from an interven-
ing outbreak in 1972. The differences in CVB5 nucleotide
sequences in Kopecka et al’s study (< 7.2%) were similar
to those reported in this study (0.3–10%).
To date, 13 different viruses have been reported to be
associated with the development of type 1 DM in humans
and in various animal models, including Coxsackie virus
B (CVB) [27], rubella virus [28], mumps virus [29], cyto-
megalovirus [30], Epstein-Barr virus and varicella zoster
[31]. In animals, nine viruses have been reported to be asso-
ciated with the development of type 1 DM [32].
In this study, all CVB5 isolates contained the PEVKEK
sequence. Vreugdenhil et al determined the amino acid
sequence 1129–1154 of 10 different CVB4 and 11 different
CVB-like enteroviruses [20]. They showed that the viral
p2C sequence with homology to GAD is highly conserved
in CVB-like enteroviruses. In their study, within the PEVKEK
motif, a single amino acid substitution of lysine to arginine
(K–R) was observed in two of 10 CVB4 isolates. They also
demonstrated that when these CVB-like enterovirus se-
quences were compared to the published CVB4 sequence,
the homology of 100 nucleotides in the p2C gene was 79%
(74–85%). There was 76–82% nucleotide sequence homology
in our CVB5 isolates when compared with prototype CVB5
isolates.
In this study, almost all p2C nucleotide sequences in dia-
betogenic and non-diabetogenic CVB5 isolates contained
PEVKEK, which was conserved in the nucleotide sequence
of GAD. In animal studies, Ju and Yoon [33] and Chung et
al [34] demonstrated that Kilham rat virus (KRV)-induced
autoimmune diabetes in diabetes-resistant BB rats is not
due to molecular mimicry, but to a breakdown of the finely
tuned immune balance of Th1-like CD45RC+CD4+ and
Th2-like CD45RC-CD4+ T cells, resulting in selective
activation of beta cell-cytotoxic effector T cells.
Two of four type 1 DM patients were positive for GAD65
in this study, which was similar to our GAD studies of
seropositivity (54.3%) in type 1 DM patients in Taiwan [35].
Tests for GAD65 were performed several years after
admission in the studies of Chuang et al [36] and Falorni
et al [37], who observed that GAD65 positivity decreased
as the diabetes duration increased. However, our results
revealed that GAD seropositivity did not decrease as the
duration of type 1 DM increased [35].
In this study, the HLA-DR assays revealed that the four
type 1 DM patients had at least one susceptible HLA-DR
allele, such as DR3, DR4 and DR9, known in Chinese child-
onset type 1 DM [36,38]. Our HLA-DQA1, DQB1 studies
showed that the four type 1 DM patients also had at least
one genetic susceptibility allele, such as HLA-DQA1 0301,
0302, DQB1 0201 [39]. Two of these patients had the
susceptible haplotype DQA1 0301, DQB1 0201, with a
relative risk of 42.6. A third patient had the susceptible
haplotype DQA1 0501, DQB1 0201, with a relative risk of
6.6 [39].
In this study, all CVB5 isolates contained the PEVKEK
sequence, whether isolated from type 1 DM or non-diabetic
patients. Our data showed that the viral p2C sequence with
homology to GAD is highly conserved in CVB5 isolates.
There was only 2.4–3.4% nucleotide difference in our four
isolates from type 1 DM patients and only 1.7–7.1%
nucleotide difference between the type 1 DM and non-
diabetes CVB5 isolates. Other genetic and autoimmune
factors such as HLA genetic susceptibility and GAD may
also play important roles in the pathogenesis of type 1 DM.
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